Trip report vital statistics assessment and training programme British Virgin Islands, July 11-19, 1985

Informe de la mision realizada para evaluar el estado de las estadisticas vitales en las Islas Virgenes Britanicas, y estudiar la forma de mejorar los sistemas de recoleccion y entrega de datos.

South American transport statistics system (Setas)

A meeting of experts was held in Santiago, Chile on 27 and 28 October 1999 to mark the start of the project for the development of the South American Transport Statistics System (SETAS). The main objective of the meeting was to analyse different elements for the development of a SETAS pilot project. The meeting was attended by representatives of Bolivia, Brazil and Chile, the countries chosen to participate in this early stage of the project's development. Officials from the Latin American Integration Association (LAIA), and from the Statistics and Economic Projections Division and the Transport Unit, Natural Resources and Infrastructure Division of ECLAC also participated. This edition of the FAL Bulletin focuses on this regional effort, listing the specifications and components of the SETAS pilot plan and the results expected from its implementation.

South American Transport Statistics System (SETAS)- Analysis of pilot project

The SETAS pilot project was carried out by the ECLAC Transport Unit, between October 1999 and May 2000 to assess the feasibility of constructing a transport statistics information system for South America. As this would entail a major effort to establish common statistical procedures and criteria between countries, the pilot project attempted to assess the potential of using informatics techniques for standardizing a significant set of regional transport statistics variables.The pilot phase involved specialized transport statistics institutes from Bolivia, Brazil and Chile — the countries chosen to participate in the initial stage of the project. There was also participation by staff members from the Latin American Integration Association (LAIA), and from the ECLAC Statistics and Economic Projections Division, the Electronic Information Centre and the Transport Unit of the Natural Resources and Infrastructure Division.This edition of the FAL Bulletin explains on the components of the SETAS pilot project and the results obtained.

Accounting for Fetal Death: Vital Statistics and the Medicalization of Pregnancy in the United States

Recent reports by the Centers for Disease Control and Prevention have decried the high rate of fetal mortality in the contemporary United States. Much of the data about fetal and infant deaths, as well as other poor pregnancy outcomes, are tabulated and tracked through vital statistics. In this article, I demonstrate how notions of fetal death became increasingly tied to the surveillance of maternal bodies through the tabulating and tracking of vital statistics in the middle part of the twentieth century. Using a historical analysis of the revisions to the United States Standard Certificate of Live Birth, and the United States Standard Report of Fetal Death, I examine how the categories of analysis utilized in these documents becomes integrally linked to contemporary ideas about fetal and perinatal death, gestational age, and prematurity. While it is evident that there are relationships between maternal behavior and birth outcomes, in this article I interrogate the ways in which the surveillance of maternal bodies through vital statistics has naturalized these relationships. Copyright 2013 Elsevier Ltd. All rights reserved.

Safety of non-therapeutic atomoxetine exposures - a national poison data system study

AIMS This study's objective is to assess the safety of non-therapeutic atomoxetine exposures reported to the US National Poison Database System (NPDS). METHODS This is a retrospective database study of non-therapeutic single agent ingestions of atomoxetine in children and adults reported to the NPDS between 2002 and 2010. RESULTS A total of 20 032 atomoxetine exposures were reported during the study period, and 12 370 of these were single agent exposures. The median age was 9 years (interquartile range 3, 14), and 7380 were male (59.7%). Of the single agent exposures, 8813 (71.2%) were acute exposures, 3315 (26.8%) were acute-on-chronic, and 166 (1.3%) were chronic. In 10 608 (85.8%) cases, exposure was unintentional, in 1079 (8.7%) suicide attempts, and in 629 (5.1%) cases abuse. Of these cases, 3633 (29.4 %) were managed at health-care facilities. Acute-on-chronic exposure was associated with an increased risk of a suicidal reason for exposure compared with acute ingestions (odds ratio 1.44, 95% confidence interval 1.26-1.65). Most common clinical effects were drowsiness or lethargy (709 cases; 5.7%), tachycardia (555; 4.5%), and nausea (388; 3.1%). Major toxicity was observed in 21 cases (seizures in nine (42.9%), tachycardia in eight (38.1%), coma in six (28.6%), and ventricular dysrhythmia in one case (4.8%)). CONCLUSIONS Non-therapeutic atomoxetine exposures were largely safe, but seizures were rarely observed.

Comparison of whole carcass condemnation and partial carcass condemnation data for integration in a national syndromic surveillance system: The Swiss experience

We obtained partial carcass condemnation (PCC) data for cattle (2009-2010) from a Swiss slaughterhouse. Data on whole carcass condemnations (WCC) carried out at the same slaughterhouse over those years were extracted from the national database for meat inspection. We found that given the differences observed in the WCC and PCC time series, it is likely that both indicators respond to different health events in the population and that one cannot be substituted by the other. Because PCC recordings are promising for syndromic surveillance, the meat inspection database should be capable to record both WCC and PCC data in the future. However, a standardised list of reasons for PCC needs to be defined and used nationwide in all slaughterhouses.

Monitoring influenza vaccine effectiveness using the national influenza surveillance system

Background: Flu vaccine composition is reformulated on a yearly basis. As such, the vaccine effectiveness (VE) from previous seasons cannot be considered for subsequent years, and it is necessary to monitor the VE for each season. This study (MonitorEVA- monitoring vaccine effectiveness) intends to evaluate the feasibility of using the national influenza surveillance system (NISS) for monitoring the influenza VE. Material and methods: Data was collected within NISS during 2004 to 2014 seasons. We used a case-control design where laboratory confirmed incident influenza like illness (ILI) patients (cases) were compared to controls (ILI influenza negative). Eligible individuals consisted on all aged individuals that consult a general practitioner or emergency room with ILI symptoms with a swab collected within seven days of symptoms onset. VE was estimated as 1- odds ratio of being vaccinated in cases versus controls adjusted for age and month of onset by logistic regression. Sensitivity analyses were conducted to test possible effect of assumptions on vaccination status, ILI definition and timing of swabs (<3 days after onset). Results: During the 2004-2014 period, a total of 5302 ILI patients were collected but 798 ILI were excluded for not complying with inclusion criteria. After data restriction the sample size in both groups was higher than 148 individuals/ season; minimum sample size needed to detect a VE of at least 50% considering a level of significance of 5% and 80% power. Crude VE point estimates were under 45% in 2004/05, 2005/06, 2011/12 and 2013/14 season; between 50%-70% in 2006/07, 2008/09 and 2010/11 seasons, and above 70% in 2007/08 and 2012/13 season. From season 2006/07 to 2013/14, all crude VE estimates were statistically significant. After adjustment for age group and month of onset, the VE point estimates decreased and only 2008/09, 2012/13 and 2013/14 seasons were significant. Discussion and Conclusions: MonitorEVA was able to provide VE estimates for all seasons, including the pandemic, indicating if the VE was higher than 70% and less than 50%. When comparing with other observational studies, MonitorEVA estimates were comparable but less precise and VE estimates were in accordance with the antigenic match of the circulating virus/ vaccine strains. Given the sensitivity results, we propose a MonitorEVA based on: a) Vaccination status defined independently of number of days between vaccination and symptoms onset; b) use of all ILI data independent of the definition; c) stratification of VE according to time between onset and swab (< 3 and ≥3 days).

Vital statistics for New York State.

Title varies slightly.

Accident causation methodology development for the National Accident Sampling System: final report.

National Highway Traffic Safety Administration, Washington, D.C.

National Accident Sampling System sample design - phases 2 and 3 - executive summary. Final report.

National Highway Traffic Safety Administration, Washington, D.C.

National Accident Sampling System sample design - phases 2 and 3. Volume II: exhibits. Final report.

National Highway Traffic Safety Administration, Washington, D.C.